A UK report suggests that psychedelic drugs like MDMA, ketamine, LSD, and psilocybin may help treat mental illnesses, but current evidence is insufficient for routine use. Ongoing clinical trials show promise for conditions like anxiety and depression, yet researchers urge caution and further studies on safety and efficacy. Some countries are allowing compassionate use of psychedelics, while psilocybin will be legal for depression treatment in the Czech Republic starting in 2026. Teljes cikk (Euronews.com)